First-Ever Psoriatic Arthritis Awareness Day Aims to Educate on Importance of Early Diagnosis and Treatment

Celgene Unites With National Psoriasis Foundation to Elevate Awareness of Psoriatic Arthritis (PsA) and Rally Support for Patient Community

SUMMIT, N.J.–(BUSINESS WIRE)–Celgene Corporation and the National Psoriasis Foundation (NPF) have united to mark Wednesday, September 28th as the first-ever Psoriatic Arthritis (PsA) Awareness Day, a day dedicated to raising public awareness around the importance of recognition, diagnosis and treatment. People are encouraged to join the movement at GoPsADay.com to learn factors associated with PsA, help spread the word via their social channels, and to stand up and be counted for those living with this disease.

“These Psoriatic Arthritis Awareness Day efforts are just one step in addressing these needs and an important collective initiative to support the psoriatic community by recognizing those living with PsA, raising awareness of the factors associated with PsA, and providing much-needed education on the disease.”

More than 1 million Americans live with PsA, although this number may be higher given it is often underreported and misdiagnosed—particularly as symptoms are sometimes confused with other types of arthritis such as rheumatoid arthritis, gout and reactive arthritis. Some factors associated with PsA include pitted fingernails, swollen fingers and toes, foot pain, joint stiffness and/or pain, and a personal or family history of psoriasis or arthritis.

Early recognition, diagnosis and treatment of psoriatic arthritis is critical for anyone living with the disease. Those who are experiencing any of the common symptoms of PsA should contact their healthcare provider.

“Psoriatic arthritis can present significant challenges to those living with the disease, including significant pain and swelling in joints that may impact a person’s activities of daily living,” said Madelaine Feldman, MD, rheumatologist. “While there is no cure, PsA can be managed, which is why it is critical for people to know the factors associated with PsA, talk with their healthcare provider to obtain the right diagnosis, and determine a treatment plan that works for them.”

“In 85 percent of PsA patients, psoriasis occurs before joint disease, so it is critical for psoriasis patients to understand factors associated with PsA,” said Randy Beranek, president and CEO, National Psoriasis Foundation. “Through these efforts and more, we hope to help improve understanding of the disease, decrease time to diagnosis, and stress the critical importance of early treatment to help lessen the impact on patients’ overall quality of life.”

PsA Awareness Day is dedicated to education, empowerment, and action for the PsA community. Here are some ways for people to get involved and show their support:

  • Visit www.gopsaday.com to access information and tools on diagnosis and guiding an active discussion with your healthcare provider.
  • Help spread the word via social channels utilizing PsA Awareness Day social media toolkit assets, including a “5 Factors Associated With PsA” infographic and #PsADay16.

“Celgene is committed to addressing the needs of people living with psoriatic arthritis, which means understanding every point of the patient journey from diagnosis to treatment,” said Scott Smith, President, Global Inflammation & Immunology, Celgene. “These Psoriatic Arthritis Awareness Day efforts are just one step in addressing these needs and an important collective initiative to support the psoriatic community by recognizing those living with PsA, raising awareness of the factors associated with PsA, and providing much-needed education on the disease.”

To learn more about PsA and help spread the word about awareness day efforts, visit GoPsADay.com.

About National Psoriasis Foundation

National Psoriasis Foundation (NPF) is the world’s largest nonprofit serving those with psoriasis and psoriatic arthritis. Our priority is to provide the information and services people need to take control of their condition, while increasing research to find a cure. In addition to serving more than 2.1 million people annually through our health education and advocacy initiatives, NPF has funded more than $13 million in psoriatic disease research grants and fellowships. Learn more about the National Psoriasis Foundation at www.psoriasis.org.

OptiMed Recognizes Artistic Employees During Last “Art Hop” Before Final Move to New HQ

Tonight marks a bittersweet moment here at OptiMed Specialty Pharmacy: we will be participating in our last Art Hop before we move to our new national headquarters, 6480 Technology Dr., Kalamazoo, Mich. Art Hop is a free, monthly program sponsored by the Arts Council of Greater Kalamazoo and features an evening of art exhibits and events throughout downtown Kalamazoo. OptiMed has regularly participated in Art Hop since 2013, featuring dozens of artists at our downtown location, 154 S. Kalamazoo Mall.

To commemorate our final Art Hop, we are proudly recognizing and supporting those who have helped make the company what it is today: our very own employees. Tonight from 5-8 p.m., we will feature a showcase of employee artwork, including a variety of paintings, photography and a novel. Refreshments will be served.

We’ll move into our new national headquarters in mid-October. The 34,000-square-foot facility is currently wrapping up construction along 9th Street in Oshtemo Township to house our specialty pharmacy business. The project will generate approximately $1.2 million in capital investment and create approximately 80 new jobs. The new headquarters will feature a state-of-the-art dispensing system, an expansive patient management center and patient support services, and offices to house the corporate executive team.

The expansion would not have been possible without the support of the Kalamazoo community. We hope you will visit us downtown once more before our move in October!

September is Childhood Cancer Awareness Month

14191951_1130830253662905_8410251143225363818_nIn the U.S., approximately 15,780 children under the age of 21 are diagnosed with cancer every year and approximately 25 percent will not survive the disease.

To bring awareness to the types of cancer that largely affect children and help raise funds for research and family support, September is designated as Childhood Cancer Awareness Month.

OptiMed Specialty Pharmacy is participating in Childhood Cancer Awareness Month by taking part in the Gold Ribbon Campaign, which started in the late 1990s when a group of parents began discussing the need for a universal symbol that would create awareness and mobilize increased attention for childhood cancer. The gold ribbon was adopted as an international awareness symbol as part of this movement.

Throughout the month of September, OptiMed Specialty Pharmacy is selling yellow ribbons for $1 to help raise funds and promote awareness for childhood cancer. Please stop by our downtown location at 154 S. Kalamazoo Mall in downtown Kalamazoo to make a donation now.

For more information about Childhood Cancer Awareness Month, please visit www.acco.org.

Source: American Childhood Cancer Organization, ICCD International